Prévisions du marché des kits de test rapide en Amérique du Nord jusqu’en 2030 – Analyse régionale – par type (test rapide d’antigène, test rapide d’anticorps et autres), produit (kit de test rapide en vente libre et kit de test rapide professionnel), technologie (test à flux latéral , phase solide, agglutination, test immunospot et basé sur les composants cellulaires), application (test de glycémie, test de maladies infectieuses, grossesse et fertilité, tests cardiométaboliques et autres) et utilisateur final (hôpital et cliniques, soins à domicile, centres de diagnostic , et d\'autres)

BMIRE00030521 | Pages: 157 | Medical Device | Jul 2024 | Type: Regional | Status: Published
Le marché nord-américain des kits de tests rapides était évalué à 6 869,40 millions de dollars américains en 2022 et devrait atteindre 10 462,82 millions de dollars américains d’ici 2030 ; on estime qu\'il enregistrera un TCAC de 5,4 % de 2022 à 2030.

La prévalence croissante des maladies génétiques et infectieuses alimente le marché des kits de test rapide en Amérique du Nord

Un rapport 2022 de MJH Life Sciences (États-Unis ) estime que 300 000 nouveau-nés dans le monde naissent chaque année avec la drépanocytose. Selon le CDC, 1 Afro-Américain sur 500 est atteint de drépanocytose. Le dernier Rapport mondial sur le paludisme (WMR) 2022 de l\'Organisation mondiale de la santé (OMS) indique que près de 247 millions de nouveaux cas de paludisme ont été signalés dans le monde en 2021, contre 245 millions de cas enregistrés en 2020. Selon la même source , le nombre de décès dus au paludisme était de 619 000 en 2021.

Sickle SCAN est un test rapide pour l\'identification de l\'anémie falciforme avec une sensibilité et une spécificité élevées. Les tests de diagnostic rapide (TDR) aident à diagnostiquer le paludisme en détectant la présence de parasites du paludisme dans le sang humain. Lorsque l’accès à des services de microscopie de haute qualité est limité, les techniques de diagnostic radiologique sont utilisées comme alternative au diagnostic clinique ou au microscope. La pandémie de COVID-19 a eu un impact significatif sur le marché des kits de tests rapides. Presque tous les tests de diagnostic utilisaient la PCR en temps réel pour tester les personnes présentant des symptômes d’infection par le SRAS-CoV-2. Les kits de tests rapides sont presque omniprésents, robustes et fiables. Des techniques de tests rapides impliquant l\'amplification de segments spécifiques d\'ADN pour le génotypage, le clonage et l\'analyse des variations d\'un seul nucléotide sont utilisées dans la plupart des laboratoires de biologie moléculaire. Ainsi, l’incidence croissante des maladies génétiques et infectieuses propulse la croissance du marché des kits de tests rapides.

Aperçu du marché des kits de tests rapides en Amérique du Nord

L\'adoption rapide d\'outils de synthèse et d\'édition de gènes tels que CRISPR et PCR dans la recherche et la thérapeutique nécessite des tests utiles en termes de quantification rapide, d\'altérations, et observation. Les États-Unis, à la recherche de financements importants auprès d’organisations publiques et privées, devraient investir de manière significative dans des méthodologies de recherche avancées et devraient occuper une position de leader sur le marché des kits de tests rapides. Il y a eu une augmentation rapide de l’utilisation des tests à domicile entre les périodes de la pandémie à prédominance Delta et Omicron du SRAS-CoV-2. Selon le CDC, en avril 2023, plus de 70 millions de kits de test ont été expédiés aux États-Unis.

Revenus et prévisions du marché des kits de test rapide en Amérique du Nord jusqu\'en 2030 (millions de dollars américains)

Segmentation du marché des kits de test rapide en Amérique du Nord

Le marché des kits de test rapide en Amérique du Nord est segmenté en fonction du type, du produit, de la technologie, de l\'application, de l\'utilisateur final et du pays. En fonction du type, le marché des kits de test rapide en Amérique du Nord est segmenté en tests rapides d’antigènes, tests rapides d’anticorps et autres. Le segment des tests rapides d\'antigène détenait la plus grande part de marché en 2022.

En termes de produits, le marché des kits de test rapide en Amérique du Nord est divisé en kit de test rapide en vente libre et en kit de test rapide professionnel. Le segment des kits de test rapide en vente libre détenait une part de marché plus importante en 2022.

Par technologie, le marché des kits de test rapide en Amérique du Nord est segmenté en test à flux latéral, phase solide, agglutination, test immunospot et à base de composants cellulaires. Le segment des tests à flux latéral détenait la plus grande part de marché en 2022.

Sur la base des applications, le marché des kits de test rapide en Amérique du Nord est classé en tests de glycémie, tests de maladies infectieuses, grossesse et fertilité, tests cardiométaboliques et autres. . Le segment des tests de glycémie détenait la plus grande part de marché en 2022.

En termes d\'utilisateur final, le marché des kits de test rapide en Amérique du Nord est segmenté en hôpitaux et cliniques, soins à domicile, centres de diagnostic et autres. Le segment des hôpitaux et des cliniques détenait la plus grande part de marché en 2022.

En fonction des pays, le marché des kits de test rapide en Amérique du Nord est segmenté entre les États-Unis, le Canada et le Mexique. Les États-Unis ont dominé la part de marché des kits de test rapide en Amérique du Nord en 2022.

F. Hoffmann-La Roche Ltd, Becton Dickinson and Co, ARKRAY Inc, Fujirebio Europe NV, bioMerieux SA, Cepheid, Meril Life Sciences Pvt Ltd, QIAGEN NV, OraSure Technologies Inc, Guangzhou Wondfo Biotech Co Ltd, Denka Co Ltd, Abbott Laboratories, Trinity Biotech Plc, SD Biosensor Inc, Bio-Rad Laboratories Inc, Hologic Inc, DiaSorin SpA et Beckman Coulter Inc sont quelques-uns des principaux acteurs opérant sur le marché des kits de tests rapides en Amérique du Nord.

TABLE OF CONTENTS

 

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Rapid Test Kits Market - Key Industry Dynamics

4.1 Market Drivers

4.1.1 Rising Prevalence of Genetic and Infectious Diseases

4.1.2 Strategic Initiatives by Manufacturers

4.2 Market Restraints

4.2.1 Uncertainties Related to Accuracy of Results

4.3 Market Opportunities

4.3.1 Increasing Preference for PCR Techniques

4.4 Future Trends

4.4.1 Innovations in Rapid Antigen Tests

4.5 Impact Analysis

5. Rapid Test Kits Market - North America Market Analysis

5.1 Overview

5.2 Rapid Test Kits Market Revenue (US$ Mn), 2020 - 2030

6. North America Rapid Test Kits Market Analysis - by Type

6.1 Overview

6.2 Rapid Antigen Testing

6.2.1 Overview

6.2.2 Rapid Antigen Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

6.3 Rapid Antibody Testing

6.3.1 Overview

6.3.2 Rapid Antibody Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

6.4 Others

6.4.1 Overview

6.4.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Rapid Test Kits Market Analysis - by Product

7.1 Overview

7.2 Over-the-Counter Rapid Testing Kit

7.2.1 Overview

7.2.2 Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

7.3 Professional Rapid Testing Kit

7.3.1 Overview

7.3.2 Professional Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Rapid Test Kits Market Analysis - by Technology

8.1 Overview

8.2 Lateral Flow Assay

8.2.1 Overview

8.2.2 Lateral Flow Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

8.3 Solid Phase

8.3.1 Overview

8.3.2 Solid Phase: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

8.4 Agglutination

8.4.1 Overview

8.4.2 Agglutination: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

8.5 Immunospot Assay

8.5.1 Overview

8.5.2 Immunospot Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

8.6 Cellular-Component Based

8.6.1 Overview

8.6.2 Cellular-Component Based: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Rapid Test Kits Market Analysis - by Application

9.1 Overview

9.2 Blood Glucose Testing

9.2.1 Overview

9.2.2 Blood Glucose Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

9.3 Infectious Disease Testing

9.3.1 Overview

9.3.2 Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

9.3.3 Infectious Disease Testing: Rapid Test Kits Market, by Application - Revenue and Forecast to 2030 (US$ Million)

9.4 Cardiometabolic Testing

9.4.1 Overview

9.4.2 Cardiometabolic Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

9.5 Pregnancy and Fertility

9.5.1 Overview

9.5.2 Pregnancy and Fertility: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Rapid Test Kits Market Analysis - by End User

10.1 Overview

10.2 Hospital and Clinics

10.2.1 Overview

10.2.2 Hospital and Clinics: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

10.3 Diagnostic Centers

10.3.1 Overview

10.3.2 Diagnostic Centers: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

10.4 Home-Care

10.4.1 Overview

10.4.2 Home-Care: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

10.5 Others

10.5.1 Overview

10.5.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

11. North America Rapid Test Kits Market - Country Analysis

11.1 North America: Rapid Test Kits Market

11.1.1 North America: Rapid Test Kits Market - Revenue and Forecast Analysis - by Country

11.1.1.1 United States

11.1.1.1.1 Overview

11.1.1.2 United States: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

11.1.1.2.1 United States: Rapid Test Kits Market Breakdown, by Type

11.1.1.2.2 United States: Rapid Test Kits Market Breakdown, by Product

11.1.1.2.3 United States: Rapid Test Kits Market Breakdown, by Technology

11.1.1.2.4 United States: Rapid Test Kits Market Breakdown, by Application

11.1.1.2.4.1 United States: Rapid Test Kits Market Breakdown, by Infectious Disease Testing

11.1.1.2.5 United States: Rapid Test Kits Market Breakdown, by End User

11.1.1.3 Canada

11.1.1.3.1 Overview

11.1.1.4 Canada: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

11.1.1.4.1 Canada: Rapid Test Kits Market Breakdown, by Type

11.1.1.4.2 Canada: Rapid Test Kits Market Breakdown, by Product

11.1.1.4.3 Canada: Rapid Test Kits Market Breakdown, by Technology

11.1.1.4.4 Canada: Rapid Test Kits Market Breakdown, by Application

11.1.1.4.4.1 Canada: Rapid Test Kits Market Breakdown, by Infectious Disease Testing

11.1.1.4.5 Canada: Rapid Test Kits Market Breakdown, by End User

11.1.1.5 Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

11.1.1.5.1 Overview

11.1.1.6 Mexico

11.1.1.6.1 Mexico: Rapid Test Kits Market Breakdown, by Type

11.1.1.6.2 Mexico: Rapid Test Kits Market Breakdown, by Product

11.1.1.6.3 Mexico: Rapid Test Kits Market Breakdown, by Technology

11.1.1.6.4 Mexico: Rapid Test Kits Market Breakdown, by Application

11.1.1.6.4.1 Mexico: Rapid Test Kits Market Breakdown, by Infectious Disease Testing

11.1.1.6.5 Mexico: Rapid Test Kits Market Breakdown, by End User

12. Industry Landscape

12.1 Overview

12.2 Growth Strategies in the Rapid Test Kit Market

12.3 Inorganic Growth Strategies

12.3.1 Overview

12.4 Organic Growth Strategies

12.4.1 Overview

13. Company Profiles

13.1 F. Hoffmann-La Roche Ltd

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Becton Dickinson and Co

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 ARKRAY Inc

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Fujirebio Europe NV

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 bioMerieux SA

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Cepheid

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Meril Life Sciences Pvt Ltd

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 QIAGEN NV

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 OraSure Technologies Inc

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Guangzhou Wondfo Biotech Co Ltd

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

13.11 Denka Co Ltd

13.11.1 Key Facts

13.11.2 Business Description

13.11.3 Products and Services

13.11.4 Financial Overview

13.11.5 SWOT Analysis

13.11.6 Key Developments

13.12 Abbott Laboratories

13.12.1 Key Facts

13.12.2 Business Description

13.12.3 Products and Services

13.12.4 Financial Overview

13.12.5 SWOT Analysis

13.12.6 Key Developments

13.13 Trinity Biotech Plc

13.13.1 Key Facts

13.13.2 Business Description

13.13.3 Products and Services

13.13.4 Financial Overview

13.13.5 SWOT Analysis

13.13.6 Key Developments

13.14 SD Biosensor Inc

13.14.1 Key Facts

13.14.2 Business Description

13.14.3 Products and Services

13.14.4 Financial Overview

13.14.5 SWOT Analysis

13.14.6 Key Developments

13.15 Bio-Rad Laboratories Inc

13.15.1 Key Facts

13.15.2 Business Description

13.15.3 Products and Services

13.15.4 Financial Overview

13.15.5 SWOT Analysis

13.15.6 Key Developments

13.16 Hologic Inc

13.16.1 Key Facts

13.16.2 Business Description

13.16.3 Products and Services

13.16.4 Financial Overview

13.16.5 SWOT Analysis

13.16.6 Key Developments

13.17 DiaSorin SpA

13.17.1 Key Facts

13.17.2 Business Description

13.17.3 Products and Services

13.17.4 Financial Overview

13.17.5 SWOT Analysis

13.17.6 Key Developments

13.18 Beckman Coulter Inc

13.18.1 Key Facts

13.18.2 Business Description

13.18.3 Products and Services

13.18.4 Financial Overview

13.18.5 SWOT Analysis

13.18.6 Key Developments

14. Appendix

14.1 About The Insight Partners

List of Tables

Table 1. Rapid Test Kits Market Segmentation

Table 2. Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Table 3. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type

Table 4. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product

Table 5. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology

Table 6. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application

Table 7. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing

Table 8. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 9. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type

Table 10. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product

Table 11. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology

Table 12. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application

Table 13. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing

Table 14. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 15. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type

Table 16. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product

Table 17. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology

Table 18. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application

Table 19. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing

Table 20. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 21. Recent Inorganic Growth Strategies in the Rapid Test Kit Market

Table 22. Recent Organic Growth Strategies in the Rapid Test Kit Market

List of Figures

Figure 1. Rapid Test Kits Market Segmentation, By Country

Figure 2. Rapid Test Kits Market: Key Industry Dynamics

Figure 3. Rapid Test Kits Market: Impact Analysis of Drivers and Restraints

Figure 4. Rapid Test Kits Market Revenue (US$ Mn), 2020 - 2030

Figure 5. Rapid Test Kits Market Share (%) - by Type (2022 and 2030)

Figure 6. Rapid Antigen Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Rapid Antibody Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. Rapid Test Kits Market Share (%) - by Product (2022 and 2030)

Figure 10. Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Professional Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 12. Rapid Test Kits Market Share (%) - by Technology (2022 and 2030)

Figure 13. Lateral Flow Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Solid Phase: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. Agglutination: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. Immunospot Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Cellular-Component Based: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. Rapid Test Kits Market Share (%) - by Application (2022 and 2030)

Figure 19. Blood Glucose Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 20. Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 21. Cardiometabolic Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 22. Pregnancy and Fertility: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 23. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 24. Rapid Test Kits Market Share (%) - by End User (2022 and 2030)

Figure 25. Hospital and Clinics: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 26. Diagnostic Centers: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 27. Home-Care: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 28. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 29. North America: Rapid Test Kits Market, by Key Country - Revenue (2022) (US$ Million)

Figure 30. North America: Rapid Test Kits Market Breakdown, by Key Countries, 2022 and 2030 (%)

Figure 31. United States: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)

Figure 32. Canada: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)

Figure 33. Mexico: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)

Figure 34. Growth Strategies in the Rapid Test Kit Market

1. F. Hoffmann-La Roche Ltd
2. Becton Dickinson and Co
3. ARKRAY Inc
4. Fujirebio Europe NV
5. bioMerieux SA
6. Cepheid
7. Meril Life Sciences Pvt Ltd
8. QIAGEN NV
9. OraSure Technologies Inc
10. Guangzhou Wondfo Biotech Co Ltd
11. Denka Co Ltd
12. Abbott Laboratories
13. Trinity Biotech Plc
14. SD Biosensor Inc
15. Bio-Rad Laboratories Inc
16. Hologic Inc
17. DiaSorin SpA
18. Beckman Coulter Inc

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America rapid test kit market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the North America rapid test kit market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the North America rapid test kit market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3550
$2840
Site License
$4550
$3640
Enterprise License
$5550
$4440